Total Payments
$2,083
2024 Payments
$306.29
Companies
19
Transactions
98
Medicare Patients
279
Medicare Billing
$3,122
Payment Breakdown by Category
Food & Beverage$2,071 (99.4%)
Education$11.80 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,071 | 97 | 99.4% |
| Education | $11.80 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $598.76 | 23 | $0 (2024) |
| Novo Nordisk Inc | $361.51 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $249.29 | 10 | $0 (2020) |
| Lilly USA, LLC | $124.74 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $105.18 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $91.01 | 6 | $0 (2024) |
| Allergan Inc. | $82.21 | 2 | $0 (2019) |
| GlaxoSmithKline, LLC. | $77.15 | 4 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $71.50 | 1 | $0 (2017) |
| Amgen Inc. | $63.98 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $306.29 | 13 | ABBVIE INC. ($147.70) |
| 2023 | $413.56 | 19 | AbbVie Inc. ($235.02) |
| 2022 | $407.96 | 23 | ABBVIE INC. ($179.06) |
| 2021 | $59.79 | 3 | AbbVie Inc. ($36.98) |
| 2020 | $191.09 | 11 | Novo Nordisk Inc ($130.43) |
| 2019 | $113.49 | 5 | Janssen Pharmaceuticals, Inc ($67.75) |
| 2018 | $264.71 | 11 | Janssen Pharmaceuticals, Inc ($135.08) |
| 2017 | $326.19 | 13 | Avanir Pharmaceuticals, Inc. ($71.50) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Inflammation | ||||||
| 03/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: DIABETES | ||||||
| 03/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $86.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Oncology | ||||||
| 11/24/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 11/09/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Inflammation | ||||||
| 11/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 08/24/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Diabetes | ||||||
| 08/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.46 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Inflammation | ||||||
| 06/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 97 | 146 | $4,127 | $1,440 |
| 2022 | 1 | 22 | 29 | $580.00 | $279.55 |
| 2021 | 1 | 19 | 37 | $740.00 | $375.88 |
| 2020 | 7 | 141 | 165 | $3,554 | $1,027 |
Total Patients
279
Total Services
377
Medicare Billing
$3,122
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 53 | 95 | $2,755 | $904.40 | 32.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 13 | $715.00 | $450.06 | 62.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 26 | $417.04 | $57.20 | 13.7% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 12 | 12 | $240.00 | $27.84 | 11.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 29 | $580.00 | $279.55 | 48.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 19 | 37 | $740.00 | $375.88 | 50.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 30 | 38 | $1,102 | $364.61 | 33.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 16 | 20 | $400.00 | $150.80 | 37.7% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 27 | 35 | $372.00 | $135.63 | 36.5% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2020 | 21 | 22 | $330.00 | $135.26 | 41.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2020 | 23 | 24 | $960.00 | $122.72 | 12.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 13 | 13 | $130.00 | $87.36 | 67.2% |
| 85018 | Hemoglobin measurement | Office | 2020 | 11 | 13 | $260.00 | $30.46 | 11.7% |
About Dr. Jeffrey Brock, M.D
Dr. Jeffrey Brock, M.D is a Family Medicine healthcare provider based in Cheraw, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1992966352.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Brock, M.D has received a total of $2,083 in payments from pharmaceutical and medical device companies, with $306.29 received in 2024. These payments were reported across 98 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,071).
As a Medicare-enrolled provider, Brock has provided services to 279 Medicare beneficiaries, totaling 377 services with total Medicare billing of $3,122. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Cheraw, SC
- Active Since 06/18/2008
- Last Updated 03/20/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992966352
Products in Payments
- VRAYLAR (Drug) $574.44
- Ozempic (Drug) $198.05
- INVOKANA (Drug) $140.86
- XARELTO (Drug) $108.43
- FARXIGA (Drug) $105.18
- TRULICITY (Drug) $93.53
- JARDIANCE (Drug) $78.72
- TRELEGY ELLIPTA (Drug) $77.15
- NUEDEXTA (Drug) $71.50
- VIBERZI (Drug) $69.55
- Victoza (Drug) $67.94
- Otezla (Drug) $63.98
- ENTRESTO (Drug) $41.58
- UBRELVY (Drug) $36.98
- Rybelsus (Drug) $28.06
- Tresiba (Drug) $26.12
- Kerendia (Drug) $24.31
- FreeStyle Libre 2 (Device) $22.81
- FREESTYLE LIBRE 2 (Device) $20.73
- VIVITROL (Drug) $18.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cheraw
Dr. Travis Novinger, M.d, M.D
Family Medicine — Payments: $18,025
Family Medicine $18,025
John Mcleod, Md, MD
Family Medicine — Payments: $4,257
Family Medicine $4,257
Winston Plunkett, Md, MD
Family Medicine — Payments: $892.07
Family Medicine $892.07
Cathryn Aliceaacosta, Md, MD
Family Medicine — Payments: $488.95
Family Medicine $488.95
Eric Mclaine, Do, DO
Family Medicine — Payments: $416.03
Family Medicine $416.03
Benjamin Hinman, M.d, M.D
Family Medicine — Payments: $310.50
Family Medicine $310.50